by TractManager | Aug 15, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the NavDx test.
by TractManager | Aug 15, 2023 | Emerging Technology Report
Nirsevimab-alip (Beyfortus; AstraZeneca) is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and for...
by TractManager | Aug 15, 2023 | Emerging Technology Report
Avasopasem manganese (Galera Therapeutics Inc.) is an investigational intravenous superoxide dismutase mimetic intended to reduce the incidence and severity of radiation-induced oral mucositis in patients undergoing radiotherapy for head and neck cancer.
by TractManager | Aug 14, 2023 | Emerging Technology Report
The AccuCinch Ventricular Restoration System (Ancora Heart Inc.) is a transcatheter left ventricular cinching device proposed for treatment of symptomatic heart failure with reduced ejection fraction (HFrEF).
by TractManager | Aug 14, 2023 | Emerging Technology Report
Bulevirtide (Gilead Sciences Inc.) is an investigational, first-in-class, subcutaneously injected virion entry inhibitor proposed for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease.
Recent Comments